RxDoctor Payments Data

Anthony Russo, MD

Orthopaedic Surgery of the Spine · Great Falls, MTNPI 1164402707

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (55.9%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. Globus Medical accounts for 73.2% of it on its own, with 12 other manufacturers making up the rest.

$287,963in general payments, 2019–2025

Across 283 payments — averaging $1017.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$211K
  • Orthofix Medical, Inc.$50K
  • Seaspine Orthopedics Corporation$20K
  • Surgentec$2K
  • Medtronic$2K
  • Mirus, LLC$2K
  • plus $1K from 7 others
$179,779in research payments, 2019–2025

Across 26 payments — averaging $6914.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Orthofix Medical, Inc.$179K
  • Globus Medical$945

What the payments were for

  • Royalty or licence$62,36422%
  • Consulting fees$161,08256%
  • Speaking & faculty fees$20,9257%
  • Travel & lodging$36,57213%
  • Food & beverage$6,7952%
  • Education$990%
  • Entertainment$1270%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic surgery of the spine providers in Montanato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$267,520
Medicare patients
135
Services billed
639

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib25$362
Gabapentin24$166

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Great Falls

Where these figures come from

Is this you, or does something look wrong? →